140 related articles for article (PubMed ID: 38246527)
1. Characterizing Immune Infiltration in Esthesioneuroblastoma Subtypes Through Gene Expression Deconvolution.
Batchu S; Gill AS; Karsy M
World Neurosurg; 2024 Mar; 183():e928-e935. PubMed ID: 38246527
[TBL] [Abstract][Full Text] [Related]
2. Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny.
Classe M; Yao H; Mouawad R; Creighton CJ; Burgess A; Allanic F; Wassef M; Leroy X; Verillaud B; Mortuaire G; Bielle F; Le Tourneau C; Kurtz JE; Khayat D; Su X; Malouf GG
Cell Rep; 2018 Oct; 25(3):811-821.e5. PubMed ID: 30332658
[TBL] [Abstract][Full Text] [Related]
3. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
4. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
5. Microvessel density and Ki-67 labeling index in esthesioneuroblastoma: is there a prognostic role?
Singh L; Ranjan R; Madan R; Arava SK; Deepak RK; Singh MK
Ann Diagn Pathol; 2015 Dec; 19(6):391-6. PubMed ID: 26343569
[TBL] [Abstract][Full Text] [Related]
6. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
7. Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome.
Malouf GG; Casiraghi O; Deutsch E; Guigay J; Temam S; Bourhis J
Eur J Cancer; 2013 Apr; 49(6):1324-34. PubMed ID: 23312882
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Profiling and Staging in Esthesioneuroblastoma: A Single-Center Cohort Study and Systematic Review.
Henson JC; Cutler CC; Cole KL; Lucke-Wold B; Khan M; Alt JA; Karsy M
World Neurosurg; 2023 Feb; 170():e652-e665. PubMed ID: 36435382
[TBL] [Abstract][Full Text] [Related]
10. Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature.
Wu K; Avila SA; Bhuyan R; Matloob A; Del Signore AG; Hadjipanayis C; Chelnis J
Orbit; 2022 Feb; 41(1):1-14. PubMed ID: 33317383
[TBL] [Abstract][Full Text] [Related]
11. [A retrospective study about 11 cases of Esthesioneuroblastomas treated in Hospital Santa Creu i Sant Pau between 2000 and 2008 and literature review].
Muñoz F; Tresserras P; Montserrat JR; Sancho FJ; Bartumeus F
Neurocirugia (Astur); 2011 Oct; 22(5):401-17; discussion 417-8. PubMed ID: 22031159
[TBL] [Abstract][Full Text] [Related]
12. Neuroradiological and Neuropathological Changes After 177Lu-Octreotate Peptide Receptor Radionuclide Therapy of Refractory Esthesioneuroblastoma.
Schneider JR; Shatzkes DR; Scharf SC; Tham TM; Kulason KO; Buteau FA; Del Prete M; Chakraborty S; Anderson TA; Asiry S; Beauregard JM; Langer DJ; Costantino PD; Boockvar JA
Oper Neurosurg (Hagerstown); 2018 Dec; 15(6):100-109. PubMed ID: 29554305
[TBL] [Abstract][Full Text] [Related]
13. Sphenoid esthesioneuroblastoma arising from the hindmost olfactory filament.
Matsunaga M; Nakagawa T; Sakamoto T; Ito J
Auris Nasus Larynx; 2015 Apr; 42(2):170-2. PubMed ID: 25459497
[TBL] [Abstract][Full Text] [Related]
14. Possible esthesioneuroblastoma metastasis to paranasal sinuses: Clinical report and literature review.
Buohliqa L; Upadhyay S; Nicolai P; Cavalieri R; Dolci RL; Prevedello D; Carrau RL
Head Neck; 2016 Feb; 38(2):E32-6. PubMed ID: 25946111
[TBL] [Abstract][Full Text] [Related]
15. Esthesioneuroblastoma: a meta-analysis and review.
Dulguerov P; Allal AS; Calcaterra TC
Lancet Oncol; 2001 Nov; 2(11):683-90. PubMed ID: 11902539
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.
Feng L; Fang J; Zhang L; Li H; Zhou B; Chen X; Li Y; Han D
Clin Neurol Neurosurg; 2015 Nov; 138():94-8. PubMed ID: 26310690
[TBL] [Abstract][Full Text] [Related]
17. Extraprimary Local Recurrence of Esthesioneuroblastoma: Case Series and Literature Review.
Maina IW; Lehrich BM; Goshtasbi K; Su BM; Stubbs VC; Tong CCL; Kohanski MA; Lee JYK; Luu QC; Newman JG; Palmer JN; Adappa ND; Kuan EC
World Neurosurg; 2020 Dec; 144():e546-e552. PubMed ID: 32916346
[TBL] [Abstract][Full Text] [Related]
18. Hyams grading as a predictor of metastasis and overall survival in esthesioneuroblastoma: a meta-analysis.
Goshtasbi K; Abiri A; Abouzari M; Sahyouni R; Wang BY; Tajudeen BA; Hsu FPK; Cadena G; Kuan EC
Int Forum Allergy Rhinol; 2019 Sep; 9(9):1054-1062. PubMed ID: 31251848
[TBL] [Abstract][Full Text] [Related]
19. Esthesioneuroblastoma methods of intracranial extension: CT and MR imaging findings.
Yu T; Xu YK; Li L; Jia FG; Duan G; Wu YK; Li HY; Yang RM; Feng J; Ye XH; Qiu YW
Neuroradiology; 2009 Dec; 51(12):841-50. PubMed ID: 19669739
[TBL] [Abstract][Full Text] [Related]
20. Esthesioneuroblastoma - a clinicopathologic study and role of DNA topoisomerase alpha.
Sharma S; Sharma MC; Johnson MH; Lou M; Thakar A; Sarkar C
Pathol Oncol Res; 2007; 13(2):123-9. PubMed ID: 17607373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
